drugset / Trial / NCT06074809

RCT on the Treatment of Menopausal Syndrome With Chinese Medicine

NCT06074809

Phase 2 Unknown 78 enrolled Chinese University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double-blinded, randomized, placebo-controlled clinical trial. Subjects will be randomly assigned to the treatment group (Modified Guizhi Fuling granules) or placebo group (Placebo granules) for 8 weeks. Outcomes will be measured at week 8 and week 12.

Timeline

Start
2023-11-01
Primary completion
2025-10-31
Completion
2026-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Chinese medicine Traditional medicine (herbal / TCM) Oral

Indications

No indication recorded.